SCHEMBL21604124

SCHEMBL21604124

O=C(Nc1cc2c(s1)CCCC2)C1CC1(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.42
RAB9A P51151 9/20 0.41
NPC1 O15118 8/20 0.41
POLB P06746 5/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
PKM P14618 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2C19 P33261 1/20 0.40
PRNP P04156 1/20 0.40
HPGD P15428 6/20 0.40
TP53 P04637 3/20 0.40
MAPK1 P28482 2/20 0.40
SMN1; SMN2 Q16637 7/20 0.39
NPSR1 Q6W5P4 2/20 0.39
DAO P14920 1/20 0.39
NFKB1 P19838 2/20 0.39
NFKB2 Q00653 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27415414 0.81 ALDH1A1 (0.49) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL8291574 0.80 NPC1 (0.47) ALDH1A1RAB9ANPC1POLBMEN1
SCHEMBL21604092 0.76 ALDH1A1 (0.39) ALDH1A1RAB9ANPC1POLBMEN1
SCHEMBL27415416 0.75 NPC1 (0.32) ALDH1A1RAB9ANPC1CYP1A2CYP2C19
SCHEMBL11883278 0.74 ALDH1A1 (0.51) ALDH1A1RAB9ANPC1POLBMEN1
SCHEMBL6246731 0.74 ALDH1A1 (0.51) ALDH1A1RAB9ANPC1POLBMEN1
SCHEMBL27415413 0.73 EPHX2 (0.36) RAB9ANPC1KMT2ANFKB1NFKB2
SCHEMBL30554632 0.71 ALDH1A1 (0.46) ALDH1A1RAB9ANPC1POLBMEN1
SCHEMBL30554642 0.71 DAO (0.50) ALDH1A1RAB9ANPC1POLBMEN1
SCHEMBL30554624 0.71 DAO (0.46) ALDH1A1RAB9ANPC1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019243550-A1 THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE UCB Biopharma SRL (BE) 2019-12-26 WO disclosed